Laurus Labs Ltd share price logo

Laurus Labs Share Price

(LAURUSLABS)

₹536.751.83%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Laurus Labs Performance

  • Day's Low

    Day's High

    ₹531.5
    Day's Price Range
    ₹549.55
  • 52 Week's Low

    52 Week's High

    ₹373.1
    52-Week Price Range
    ₹646.2
1 Month Return-6.42 %
3 Month Return+ 11.78 %
1 Year Return+ 36.26 %
Previous Close₹546.75
Open₹541.15
Volume17.91L
Upper Circuit-
Lower Circuit-
Market Cap₹29,483.63Cr

Laurus Labs Key Statistics

P/E Ratio

147.37

PEG Ratio

640.75

Market Cap

₹29,483.63 Cr

P/B Ratio

5.02

EPS

3.12

Dividend Yield

0.2

Sector

Pharmaceuticals

ROE

5.41

Laurus Labs Analyst Rating

based on 14 analysts

HOLD

40.00%

Buy

13.33%

Hold

46.67%

Sell

Based on 14 analysts offering long term price targets for Laurus Labs. An average target of ₹526.5

Source: S&P Global Market Intelligence

Laurus Labs Share analysis

Laurus Labs price forecast by 14 analysts

Downside of-3.70%

High

₹720

Target

₹526.50

Low

₹293

Laurus Labs target price ₹526.5, a slight downside of -3.7% compared to current price of ₹536.75. According to 14 analysts rating.

Source: S&P Global Market Intelligence

Key events for Laurus Labs Ltd

  • Laurus Labs Faces Short-Term Decline Amid Selling - 18 Feb, 2025

    Laurus Labs shares have recently declined 15% over five days, influenced by mutual fund selling. However, the stock has shown a 27% increase over six months.
  • Laurus Labs Faces Continued Decline Amid Market Trends - 14 Feb, 2025

    Laurus Labs Ltd is down 9.03% today, marking its fifth consecutive session of losses. Despite a 39.28% increase over the past year, the stock has lost 1.82% in the last month, while the Nifty Pharma index has also declined by 5.47%. The stock's current PE ratio is 129.77 based on TTM earnings.
  • Laurus Labs Continues Upward Trend with Analyst Buy - 06 Feb, 2025

    Laurus Labs Ltd has gained for three straight sessions, currently at Rs 638.45, up 1.16%. An analyst recommends a buy with a target of ₹660.
  • Laurus Labs Stock Recommended for Bullish Trade - 03 Feb, 2025

    Laurus Labs is highlighted as a strong buy at 617, with a target range of 645-665 and a stop loss set at 584, indicating bullish sentiment.
  • Laurus Labs Stock Surges on US HIV Treatment Waiver - 30 Jan, 2025

    Laurus Labs shares experienced significant gains on January 30, 2025, following the US approval of an emergency humanitarian waiver for HIV treatment, resuming funding for the PEPFAR program, and a positive outlook for its CDMO business. The stock jumped by up to 10% during the day, reflecting strong market confidence.
  • Laurus Labs Shares Plummet Amid Aid Concerns - 27 Jan, 2025

    Laurus Labs' shares dropped nearly 15% due to fears over US aid suspension affecting ARV sales. The company reassured investors about minimal impact on procurement.
  • Laurus Labs Reports Strong Q3 Results and Stock Surge - 24 Jan, 2025

    Laurus Labs Ltd announced impressive Q3 FY25 results, with revenue up 18.4% and net profit soaring 297%. The EBITDA margin returned to 20.2%, boosting investor confidence and leading to a stock surge.
  • Laurus Labs Subsidiary Receives FDA Observation - 22 Jan, 2025

    Laurus Labs announced that its US subsidiary, Laurus Generics Inc, received a Form 483 with one observation from the USFDA following a post-marketing inspection. The company plans to address the observation within the stipulated timelines.
  • Laurus Labs Shows Strong Support and Upward Potential - 21 Jan, 2025

    Laurus Labs has found strong support at ₹580, with trends indicating steady buying interest. The stock shows potential for upward traction, suggesting buying opportunities.
  • Laurus Labs Ltd Gains for Third Straight Session - 20 Jan, 2025

    Laurus Labs Ltd surged 3.11% to Rs 585.45, marking its third consecutive day of gains. The stock has risen 46.75% over the past year, outperforming NIFTY and Nifty Pharma index. Volume today was 9.9 lakh shares, below the monthly average of 18.42 lakh shares.

Insights on Laurus Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 12.51 Cr → 92.3 Cr (in ₹), with an average increase of 57.7% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 27.18% to 27.62% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.19K Cr → 1.42K Cr (in ₹), with an average increase of 8.1% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.69% to 34.08% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 133.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 23.6%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 26.08% to 25.56% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 8.25% to 7.62% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LAURUSLABS stock has moved down by -9.0%

Laurus Labs Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹1,194.92Cr (-)₹1,439.67Cr (↑20.48%)₹1,194.91Cr (↓17.00%)₹1,223.70Cr (↑2.41%)₹1,415.05Cr (↑15.64%)
Net Income₹25.17Cr (-)₹75.32Cr (↑199.25%)₹12.21Cr (↓83.79%)₹17.72Cr (↑45.13%)₹90.61Cr (↑411.34%)
Net Profit Margin2.11% (-)5.23% (↑147.87%)1.02% (↓80.50%)1.45% (↑42.16%)6.40% (↑341.38%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,740.30Cr (-)₹6,690.16Cr (↑16.55%)₹7,003.02Cr (↑4.68%)₹7,721.10Cr (↑10.25%)
Total Liabilities₹3,028.06Cr (-)₹3,301.95Cr (↑9.05%)₹2,946.20Cr (↓10.77%)₹3,514.05Cr (↑19.27%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹344.68Cr (-)₹694.45Cr (↑101.48%)₹822.97Cr (↑18.51%)₹881.55Cr (↑7.12%)₹658.54Cr (↓25.30%)

Index Inclusions

Nifty Healthcare

₹13,375.50

0.09 (11.65%)

BSE Healthcare

₹40,263.69

0.4 (159.55%)

S&P BSE 250 SmallCap

₹5,924.26

1.21 (71.08%)

BSE Mid-Cap

₹40,854.88

1.18 (478.2%)

NIFTY PHARMA

₹20,785.75

-0.16 (-34.25%)

Nifty MidSmallcap 400

₹17,400.70

1.28 (219.75%)

Nifty Smallcap 50

₹7,625.95

1.56 (116.9%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Nifty 500

₹20,831.10

0.48 (99.65%)

Nifty Small 100

₹15,747.70

1.43 (221.8%)

Nifty Smallcap 250

₹14,767.30

-58.56 (-20868.65%)

S&P BSE 400 MidSmallCap

₹10,582.55

1.23 (128.5%)

BSE 500

₹32,757.57

0.46 (149.8%)

Laurus Labs Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
27.62%
1.64
Foreign Institutions
25.56%
-2.03
Mutual Funds
7.62%
-7.64
Retail Investors
34.08%
1.15
Others
5.12%
6.74

Laurus Labs Key Indicators

Details20202021202220232024
Return On Equity %15.6842.2324.5920.435.41
Details20202021202220232024
Return On Assets %6.5717.1312.3711.282.08
Details20202021202220232024
Book Value Per Share (₹)33.0248.4162.3774.9676.28
Details20202021202220232024
Earning Per Share (₹)4.7818.3315.4914.793.12

Laurus Labs Valuation

Laurus Labs in the last 5 years

  • Overview

  • Trends

Lowest (16.96x)

March 28, 2023

Industry (51.87x)

February 19, 2025

Today (147.37x)

February 19, 2025

Highest (242.70x)

December 6, 2024

LowHigh

Laurus Labs Earnings and Dividends

  • Laurus Labs Ltd Earnings Results

    Laurus Labs Ltd’s net profit jumped 298.88% since last year same period to ₹92.30Cr in the Q3 2024-2025. On a quarterly growth basis, Laurus Labs Ltd has generated 365.22% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Laurus Labs Ltd Dividends October,2024

    In the quarter ending September 2024, Laurus Labs Ltd has declared dividend of ₹0.40 - translating a dividend yield of 0.15%.

    Read More about Dividends

Laurus Labs Technicals Summary

Bearish

Neutral

Bullish

Bearish

Laurus Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.

Laurus Labs Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
HOLD₹29,483.63 Cr104.16%0.67₹168 Cr₹5,040 Cr
HOLD₹21,840.22 Cr12.28%0.55₹362 Cr₹2,226 Cr
HOLD₹56,694.14 Cr15.67%0.56₹1,811 Cr₹12,667 Cr
BUY₹9,521.57 Cr9.92%0.64₹119 Cr₹547 Cr
BUY₹3,805.61 Cr3.46%0.54₹69 Cr₹571 Cr

About Laurus Labs

Laurus Labs is a fully integrated pharmaceutical and biotechnology company with a leadership position in the production of generic active pharmaceutical ingredients (APIs) in high-growth therapeutic areas like antiretrovirals (ARVs), Hepatitis C, and Oncology. The company operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh, and has invested significantly in their RD and manufacturing infrastructure, having launched 59 products since its inception in 2005. Its key customers include Aspen Pharmacare Limited, Aurobindo Pharma Limited, Cipla Limited, Mylan Laboratories Limited, NATCO Pharma, Strides Shasun, among others. It has 34 owned patents plus 152 pending patent applications in various countries. It is increasingly focused on their integrated generics finished dosage forms FDFs business, having acquired of Sriam Labs and Richcore Lifesciences in the recent years. During 2020, it launched Hydroxychloroquine, initiated TLD supplies for the Global Fund tender, and bargained partnerships with various private and public organizations. On 2022, it infused capital in Laurus Generics Inc . and infused around Rs 46 crore to acquire a stake in Immunoadoptive Cell Therapy Private Limited, among other expansions and operations.

Share Price: ₹536.75 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹29,483.63Cr as of today
Revenue: ₹1,415.05Cr as on December 2024 (Q4 24)
Net Profit: ₹90.61Cr as on December 2024 (Q4 24)
Listing date: 19 Dec, 2016
Chairperson Name: M V G Rao
OrganisationLaurus Labs
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Laurus Labs Ltd

What is Laurus Labs Ltd price today?

Laurus Labs Ltd share price today stands at ₹536.75, Open: ₹541.15, Previous Close: ₹546.75, High: ₹549.55, Low: ₹531.5, 52 Week High: ₹646.2, 52 Week Low: ₹373.1.

How to Buy Laurus Labs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Laurus Labs Ltd shares

Is Laurus Labs Ltd listed on NSE?

Laurus Labs Ltd is listed on NSE

Is Laurus Labs Ltd listed on BSE?

Laurus Labs Ltd is listed on BSE

What are today's High and Low prices of Laurus Labs Ltd?

  • Today's highest price of Laurus Labs Ltd is ₹549.55.
  • Today's lowest price of Laurus Labs Ltd is ₹531.5.

What are today's traded volumes of Laurus Labs Ltd?

Today's traded volume of Laurus Labs Ltd(LAURUSLABS) is 17.91L.

What is today's market capitalisation of Laurus Labs Ltd?

Today's market capitalisation of Laurus Labs Ltd(LAURUSLABS) is ₹29483.63Cr.

What is the 52 Week High and Low Range of Laurus Labs Ltd?

Laurus Labs Ltd (LAURUSLABS)
Price
52 Week High
₹646.2
52 Week Low
₹373.1

How much percentage Laurus Labs Ltd is down from its 52 Week High?

Laurus Labs Ltd (LAURUSLABS) share price is ₹536.75. It is down -16.94% from its 52 Week High price of ₹646.2

How much percentage Laurus Labs Ltd is up from its 52 Week low?

Laurus Labs Ltd (LAURUSLABS) share price is ₹536.75. It is up 43.86% from its 52 Week Low price of ₹373.1

What are the historical returns of Laurus Labs Ltd?

Laurus Labs Ltd (LAURUSLABS)
Returns
1 Day Returns
-10%
1 Month Returns
-6.42%
3 Month Returns
11.78%
1 Year Returns
36.26%

What is the PE ratio of Laurus Labs Ltd today?

PE Ratio of Laurus Labs Ltd is 147.37

PE ratio = Laurus Labs Ltd Market price per share / Laurus Labs Ltd Earnings per share